CXC chemokine ligand 17 (CXCL17), a novel CXC chemokine consisting of 119 amino acids, is negatively correlated with CD4+ T cell aggregation and promotes BC growth and metastasis through significant pro-angiogenic effects. This evidence concerns the gene CXCL17 and breast cancer.